|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| (11) | Patento numeris | 2125894 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08742182.2 |
| Europos patento paraiškos padavimo data | 2008-03-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-12-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-12-19 |
| (46) | Apibrėžties vertimo paskelbimo data | 2019-03-25 |
| (86) | Numeris | PCT/US2008/003735 |
| Data | 2008-03-21 |
| (87) | Numeris | WO 2008/118356 |
| Data | 2008-10-02 |
| (30) | Numeris | Data | Šalis |
| 919816 P | 2007-03-22 | US | |
| 919938 P | 2007-03-22 | US | |
| 920495 P | 2007-03-27 | US |
| (72) |
BURKLY, Linda C., US
FERRANT-ORGETTAS, Janine L., US
GARBER, Ellen A., US
HSU, Yen-ming, US
SU, Lihe, US
TAYLOR, Frederick R., US
ADAMS, Ralph, GB
BROWN, Derek Thomas, GB
POPPLEWELL, Andrew George, GB
ROBINSON, Martyn Kim, GB
SHOCK, Anthony, GB
TYSON, Kerry Louise, GB
|
| (73) |
Biogen MA Inc.,
225 Binney Street, Cambridge, MA 02142,
US
UCB Biopharma SRL, Allée de la Recherche 60, 1070 Brussels, BE |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Prisijungiantys baltymai, įskaitant antikūnus, antikūno dariniai ir antikūno fragmentai, kurie specifiškai suriša CD154, ir jų panaudojimas |
| BINDING PROTEINS, INCLUDING ANTIBODIES, ANTIBODY DERIVATIVES AND ANTIBODY FRAGMENTS, THAT SPECIFICALLY BIND CD154 AND USES THEREOF |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2026-02-23 | 19 | 347.00 EUR |
| 2027-03-21 |